Top Markets
#1 Akedo Akedo +54.88%
#2 Glidr Glidr +51.75%
#3 DOVU DOVU +49.11%
#4 Velvet Velvet +43.34%
#5 Black Phoenix Black Phoenix +34.52%
#6 τemplar τemplar +22.75%
#7 Cross Cross +19.33%
#8 Ribbita by Virtuals Ribbita by Virtuals +16.59%
#9 Bitway Bitway +15.40%
#10 Not in Employment, Education, or Training Not in Employment, Education, or Training +15.38%
Coin of the day
Akedo Akedo
Innstillinger
Språk
NORSK
Valuta
USD
Tema
Evofem Biosciences, Inc. Evofem Biosciences, Inc.

Evofem Biosciences, Inc.

EVFM
Rangering i aksjer #38408
Evofem Biosciences, Inc. operates as a biopharmaceutical enterprise dedicated... Evofem Biosciences, Inc. operates as a biopharmaceutical enterprise dedicated to innovating and bringing to market treatments that address critical underserved areas in women's sexual and reproductive health. Their leading commercial offering is Phexxi, a vaginal gel specifically designed as a contraceptive. Additionally, the company is actively advancing EVO100, an antimicrobial vaginal gel under development, intended to prevent the urogenital spread of both Chlamydia trachomatis and Neisseria gonorrhoeae infections in women. The company's main office is situated in San Diego, California.
Aksjekurs
$0.007524
Markedsverdi
$997.16K
Endring (1 dag)
-5.95%
Endring (1 år)
-22.43%
Land
US
Handel Evofem Biosciences, Inc. (EVFM)

Kategori

Healthcare
Aksjeprishistorikk for Evofem Biosciences, Inc. (EVFM)
Høyeste sluttskurs: $0.01 den 2026-08-01

Laveste sluttskurs: $125.17K den 2014-11-01
Aksjeprishistorikk for Evofem Biosciences, Inc. fra 2014 til 2026
Årlig aksjeprisytelse
År Ytelse
2026 (TTM) -6.91%
2025 7.85%
2024 -86.14%
2023 -99.23%
2022 -98.83%
2021 -81.81%
2020 -64.76%
2019 68.56%
2018 -60.71%
2017 48.90%
2016 -76.12%
2015 -40.99%
2014 0.00%
Aksjepris for lignende selskaper eller konkurrenter
Selskap Aksjepris Endring 1år% Land
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $505.24 29.45%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $846.09 29.68%
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 $731.69 7.13%
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 $1.07K -6.40%
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 $251.82 11.25%
BE